Development of a robust and generalizable algorithm "gQuant" for accurate normalizer gene selection in qRT-PCR analysis.


Journal

Scientific reports
ISSN: 2045-2322
Titre abrégé: Sci Rep
Pays: England
ID NLM: 101563288

Informations de publication

Date de publication:
13 08 2024
Historique:
received: 01 02 2024
accepted: 03 07 2024
medline: 14 8 2024
pubmed: 14 8 2024
entrez: 13 8 2024
Statut: epublish

Résumé

The emergent role of nucleic acid-based biomarkers-microRNAs(miRNAs), long non-coding RNAs(lncRNAs), and messenger RNAs(mRNAs), is becoming increasingly prominent in disease diagnostics and risk assessment. qRT-PCR is the primary analytical method for quantitative measurement of biomarkers. Yet, the relative infancy of non-coding RNAs recognition as biomarkers poses a challenge due to the absence of a consensus on a universally accepted normalizer gene, an absolute requirement for accurate quantification. Current tools normalizer selection are fraught with statistical limitations and suboptimal graphical user interface for data visualisation. These deficiencies underscore the necessity for a balanced tool tailored to handle qRT-PCR datasets. Addressing the identified challenges, we have developed 'gQuant' tool crafted to address these limitations. We employed voting classifiers that combine predictions from multiple statistical methods. Tool's efficacy was validated through different available and in house data derived from urinary exosomal miRNAs datasets. Comparative analysis with existing tools revealed that their integrated methodologies could skew the ranking of normalizer genes, whereas 'gQuant' consistently yielded rankings characterised by lower standard-deviation, reduced covariance, and enhanced kernel density estimation values. Given 'gQuant's' promising performance, normalizer gene identification will be greatly improved, improving precision of gene expression quantification in a variety of research scenarios. The gQuant tool developed for this study is available for public use and can be accessed at [ https://github.com/ABHAYHBB/gQuant-Tool ]."

Identifiants

pubmed: 39138232
doi: 10.1038/s41598-024-66770-y
pii: 10.1038/s41598-024-66770-y
doi:

Substances chimiques

MicroRNAs 0
RNA, Messenger 0
RNA, Long Noncoding 0
Biomarkers 0

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

18774

Subventions

Organisme : Banaras Hindu University
ID : 6031-B-21966
Organisme : Banaras Hindu University
ID : 3254/31.02

Informations de copyright

© 2024. The Author(s).

Références

Ye, J., Xu, M., Tian, X., Cai, S. & Zeng, S. Research advances in the detection of miRNA. J. Pharm. Anal. 9, 217–226 (2019).
doi: 10.1016/j.jpha.2019.05.004 pubmed: 31452959 pmcid: 6702429
Harshitha, R. & Arunraj, D. R. Real-time quantitative PCR: A tool for absolute and relative quantification. Biochem. Mol. Biol. Educ. 49, 800–812 (2021).
doi: 10.1002/bmb.21552 pubmed: 34132460
Smith, T. A. D. et al. Selection of endogenous control genes for normalising gene expression data derived from formalin-fixed paraffin-embedded tumour tissue. Sci. Rep. 10, 17258 (2020).
doi: 10.1038/s41598-020-74380-7 pubmed: 33057113 pmcid: 7560892
Suzuki, T., Higgins, P. J. & Crawford, D. R. Control selection for RNA quantitation. Biotechniques 29, 332–337 (2000).
doi: 10.2144/00292rv02 pubmed: 10948434
Identification of miR-23a as a novel microRNA normalizer for relative quantification in human uterine cervical tissues | Experimental & Molecular Medicine. https://www.nature.com/articles/emm201139 .
Danese, E. et al. Reference miRNAs for colorectal cancer: analysis and verification of current data. Sci. Rep. 7, 8413 (2017).
doi: 10.1038/s41598-017-08784-3 pubmed: 28827728 pmcid: 5567181
Reference Genes for qPCR-Based miRNA Expression Profiling in 14 Human Tissues - PubMed. https://pubmed.ncbi.nlm.nih.gov/35354155/ .
Jacobsen, K. S. et al. Identification of valid reference genes for microRNA expression studies in a hepatitis B virus replicating liver cell line. BMC Res. Notes 9, 38 (2016).
doi: 10.1186/s13104-016-1848-2 pubmed: 26801621 pmcid: 4724106
Xie, F., Wang, J. & Zhang, B. RefFinder: a web-based tool for comprehensively analyzing and identifying reference genes. Funct. Integr. Genomics 23, 125 (2023).
doi: 10.1007/s10142-023-01055-7 pubmed: 37060478
Bhatia, A., Upadhyay, A. K. & Sharma, S. miRNAs are now starring in “No Time to Die: Overcoming the chemoresistance in cancer”. IUBMB Life 75, 238–256 (2023).
doi: 10.1002/iub.2652 pubmed: 35678612
Condrat, C. E. et al. miRNAs as biomarkers in disease: Latest findings regarding their role in diagnosis and prognosis. Cells 9, 276 (2020).
doi: 10.3390/cells9020276 pubmed: 31979244 pmcid: 7072450
Recent advances in the roles of exosomal microRNAs (exomiRs) in hematologic neoplasms: pathogenesis, diagnosis, and treatment - PMC. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10152632/ .
Piao, X.-M., Cha, E.-J., Yun, S. J. & Kim, W.-J. Role of exosomal miRNA in bladder cancer: A promising liquid biopsy biomarker. Int. J. Mol. Sci. 22, 1713 (2021).
doi: 10.3390/ijms22041713 pubmed: 33567779 pmcid: 7915637
Mugoni, V., Ciani, Y., Nardella, C. & Demichelis, F. Circulating RNAs in prostate cancer patients. Cancer Lett. 524, 57–69 (2022).
doi: 10.1016/j.canlet.2021.10.011 pubmed: 34656688
Zidan, H. E., Abdul-Maksoud, R. S., Elsayed, W. S. H. & Desoky, E. A. M. Diagnostic and prognostic value of serum miR-15a and miR-16-1 expression among egyptian patients with prostate cancer. IUBMB Life 70, 437–444 (2018).
doi: 10.1002/iub.1733 pubmed: 29522280
Sewer, A. et al. Assessment of a novel multi-array normalization method based on spike-in control probes suitable for microRNA datasets with global decreases in expression. BMC Res. Notes 7, 302 (2014).
doi: 10.1186/1756-0500-7-302 pubmed: 24886675 pmcid: 4077261
Pagacz, K. et al. A systemic approach to screening high-throughput RT-qPCR data for a suitable set of reference circulating miRNAs. BMC Genom. 21, 111 (2020).
doi: 10.1186/s12864-020-6530-3
Lekchnov, E. A. et al. Searching for the novel specific predictors of prostate cancer in urine: The analysis of 84 miRNA expression. Int J Mol Sci 19, 4088 (2018).
doi: 10.3390/ijms19124088 pubmed: 30562989 pmcid: 6320807
Jain, G. et al. Urinary extracellular vesicles miRNA—A new era of prostate cancer biomarkers. Front Genet 14, 1065757 (2023).
doi: 10.3389/fgene.2023.1065757 pubmed: 36741322 pmcid: 9895092
Changes in the transcriptional profile in response to overexpression of the osteopontin-c splice isoform in ovarian (OvCar-3) and prostate (PC-3) cancer cell lines | BMC Cancer | Full Text. https://bmccancer.biomedcentral.com/articles/ https://doi.org/10.1186/1471-2407-14-433 .
GEO Accession viewer. https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE57888 .
Siddaiah, R. et al. MicroRNA signatures associated with bronchopulmonary dysplasia severity in tracheal aspirates of preterm infants. Biomedicines 9, 257 (2021).
doi: 10.3390/biomedicines9030257 pubmed: 33807742 pmcid: 8000397
GEO Accession viewer. https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE239868 .
Bryzgunova, O. E. et al. Comparative study of extracellular vesicles from the urine of healthy individuals and prostate cancer patients. PLoS One 11, e0157566 (2016).
doi: 10.1371/journal.pone.0157566 pubmed: 27305142 pmcid: 4909321
Rodríguez, M. et al. Identification of non-invasive miRNAs biomarkers for prostate cancer by deep sequencing analysis of urinary exosomes. Mol. Cancer 16, 156 (2017).
doi: 10.1186/s12943-017-0726-4 pubmed: 28982366 pmcid: 5629793

Auteurs

Abhay Kumar Pathak (AK)

DST-CIMS, Institute of Science, Banaras Hindu University, Varanasi, India.

Sukhad Kural (S)

Department of Urology, Institute of Medical Sciences, Banaras Hindu University, Varanasi, India.

Shweta Singh (S)

Centre for Genetic Disorders, Institute of Science, Banaras Hindu University, Varanasi, India.

Lalit Kumar (L)

Department of Urology, Institute of Medical Sciences, Banaras Hindu University, Varanasi, India.

Mahima Yadav (M)

Department of Pathology, Institute of Medical Sciences, Banaras Hindu University, Varanasi, India.

Manjari Gupta (M)

DST-CIMS, Institute of Science, Banaras Hindu University, Varanasi, India.

Parimal Das (P)

Centre for Genetic Disorders, Institute of Science, Banaras Hindu University, Varanasi, India.

Garima Jain (G)

Centre for Genetic Disorders, Institute of Science, Banaras Hindu University, Varanasi, India. garima.jain@bhu.ac.in.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH